Moreover, administration of anti-VEGF antibody reportedly promotes painful sensory neuropathy [72], while VEGF administration stimulates functional recovery of injured nerves accompanied by pain reduction in animals [73]. The gene discussed is VEGFA; the disease is Sensory neuropathy.